Search research articles
Contact Us
Filters
Showing results (461-470 of 471) with videos related to
Page
of 48
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2020
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Dana Lukin, David Faleck, Ronghui Xu, et al.
Inflammatory Bowel Diseases
|
May 4, 2019
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes
Jenna L Koliani-Pace, Siddharth Singh, Michelle Luo, et al.
Inflammatory Bowel Diseases
|
June 5, 2024
Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review
Katherine Falloon, Zahra Dossaji, Pooja Mude, et al.
Gut
|
November 1, 2016
Development of an index to define overall disease severity in IBD
Corey A Siegel, Cynthia B Whitman, Brennan M R Spiegel, et al.
The American Journal of Gastroenterology
|
November 4, 2018
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The American Journal of Gastroenterology
|
June 28, 2018
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The Lancet. Gastroenterology & Hepatology
|
March 5, 2023
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Johan Burisch, Mirabella Zhao, Selwyn Odes, et al.
Gastroenterology
|
June 2, 2018
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease
Parambir S Dulai, Brigid S Boland, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 17, 2020
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis
Parambir S Dulai, Siddharth Singh, Niels Vande Casteele, et al.
The American Journal of Gastroenterology
|
October 3, 2022
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
Amanda M Johnson, Maria Barsky, Waseem Ahmed, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 471) with videos related to
Sort By:
Page
of 48
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2020
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Dana Lukin, David Faleck, Ronghui Xu, et al.
Inflammatory Bowel Diseases
|
May 4, 2019
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes
Jenna L Koliani-Pace, Siddharth Singh, Michelle Luo, et al.
Inflammatory Bowel Diseases
|
June 5, 2024
Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review
Katherine Falloon, Zahra Dossaji, Pooja Mude, et al.
Gut
|
November 1, 2016
Development of an index to define overall disease severity in IBD
Corey A Siegel, Cynthia B Whitman, Brennan M R Spiegel, et al.
The American Journal of Gastroenterology
|
November 4, 2018
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The American Journal of Gastroenterology
|
June 28, 2018
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The Lancet. Gastroenterology & Hepatology
|
March 5, 2023
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Johan Burisch, Mirabella Zhao, Selwyn Odes, et al.
Gastroenterology
|
June 2, 2018
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease
Parambir S Dulai, Brigid S Boland, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 17, 2020
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis
Parambir S Dulai, Siddharth Singh, Niels Vande Casteele, et al.
The American Journal of Gastroenterology
|
October 3, 2022
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
Amanda M Johnson, Maria Barsky, Waseem Ahmed, et al.
Page
of 48